Plain-English translation of NCT07728539 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Atrial fibrillation is a condition where your heart beats irregularly, which can increase your risk of stroke. This trial is testing whether using very high-power radiofrequency ablation during a catheter procedure works better and is safer than the standard low-power approach. Both methods aim to isolate the pulmonary veins in your heart to restore a normal heartbeat.
Current standard ablation procedures work well for many patients, but doctors want to know if using higher power settings for shorter periods might be even more effective, create better long-term results, and potentially be safer overall.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive ablation using either the standard low-power technique or the newer high-power short-duration technique. The procedure itself is similar in both groups—a catheter is guided through your blood vessels to your heart to isolate the pulmonary veins. You will need to attend follow-up visits to monitor how well the procedure worked and check for any side effects.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Russia